EPHB2

LY3473329 : Therapeutic Potential of Lipoprotein(a) Inhibitors

Pifithrin-α : Pifithrin-a protects against DNA damage-induced apoptosis downstream of mitochondria independent of p53

AG-221 : Enasidenib in patients with mutant IDH2 myelodysplastic syndromes: a phase 1 subgroup analysis of the multicentre, AG221-C-001 trial

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>